| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
First Department of Medicine and Department of Radiology, Hokkaido University School of Medicine, Sapporo, Japan
Correspondence to:
Dr Masaharu Nishimura, First Department of Medicine, Hokkaido University School of Medicine, N-15 W-7, Kita-Ku, Sapporo 060-8638, Japan; ma-nishi{at}med.hokudai.ac.jp
Background: Airflow limitation in chronic obstructive pulmonary disease (COPD) is caused by a mixture of small airway disease and emphysema, the relative contributions of which may vary among patients. Phenotypes of COPD classified purely based on severity of emphysema are not well defined and may be different from the classic phenotypes of "pink puffers" and "blue bloaters".
Methods: To characterise clinical phenotypes based on severity of emphysema, 274 subjects with COPD were recruited, excluding those with physician-diagnosed bronchial asthma. For all subjects a detailed interview of disease history and symptoms, quality of life (QOL) measurement, blood sampling, pulmonary function tests before and after inhalation of salbutamol (0.4 mg) and high-resolution CT scanning were performed.
Results: Severity of emphysema visually evaluated varied widely even among subjects with the same stage of disease. No significant differences were noted among three groups of subjects classified by severity of emphysema in age, smoking history, chronic bronchitis symptoms, blood eosinophil count, serum IgE level or bronchodilator response. However, subjects with severe emphysema had significantly lower body mass index (BMI) and poorer QOL scores, evaluated using St George’s Respiratory Questionnaire (SGRQ), than those with no/mild emphysema (mean (SD) BMI 21.2 (0.5) vs 23.5 (0.3) kg/m2, respectively; SGRQ total score 40 (3) vs 28 (2), respectively; p<0.001 for both). These characteristics held true even if subjects with the same degree of airflow limitation were chosen.
Conclusions: The severity of emphysema varies widely even in patients with the same stage of COPD, and chronic bronchitis symptoms are equally distributed irrespective of emphysema severity. Patients with the phenotype in which emphysema predominates have lower BMI and poorer health-related QOL.
Abbreviations: BDR, bronchodilator response; BMI, body mass index; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; HRCT, high-resolution computed tomography; LAA, low attenuation area; QOL, quality of life; SGRQ, St George’s Respiratory Questionnaire; TLCO, carbon monoxide transfer factor; VA, alveolar volume
This article has been cited by other articles:
|
|
 |
|
  I. Rahman Review: Antioxidant therapeutic advances in COPD Therapeutic Advances in Respiratory Disease, December 1, 2008; 2(6): 351 - 374. [Abstract] [PDF]
|
|
|
|
 |
|
 B. D. Patel, H. O. Coxson, S. G. Pillai, A. G. N. Agusti, P. M. A. Calverley, C. F. Donner, B. J. Make, N. L. Muller, S. I. Rennard, J. Vestbo, et al. Airway Wall Thickening and Emphysema Show Independent Familial Aggregation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 500 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hizawa, H. Makita, Y. Nasuhara, M. Hasegawa, K. Nagai, Y. Ito, T. Betsuyaku, S. Konno, M. Nishimura, and the Hokkaido COPD Cohort Study Group Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients Eur. Respir. J., August 1, 2008; 32(2): 372 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lynch Diagnosis and management of COPD InnovAiT, March 1, 2008; 1(3): 222 - 232. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
